Cargando…

Serum Inflammatory Biomarkers in Patients with Nonarteritic Anterior Ischemic Optic Neuropathy

PURPOSE: To evaluate the neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), platelet-to-lymphocyte ratio (PLR), and systemic immune-inflammation index (SII) in patients with non-arteritic anterior ischemic optic neuropathy (NAION). METHODS: Fifty-six patients with NAION and 60...

Descripción completa

Detalles Bibliográficos
Autores principales: Koçak, Nurullah, Eraydın, Bilge, Turunç, Mustafa, Yeter, Volkan, Günögr, İnci
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Ophthalmological Society 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738228/
https://www.ncbi.nlm.nih.gov/pubmed/33307608
http://dx.doi.org/10.3341/kjo.2020.0075
_version_ 1783623087070117888
author Koçak, Nurullah
Eraydın, Bilge
Turunç, Mustafa
Yeter, Volkan
Günögr, İnci
author_facet Koçak, Nurullah
Eraydın, Bilge
Turunç, Mustafa
Yeter, Volkan
Günögr, İnci
author_sort Koçak, Nurullah
collection PubMed
description PURPOSE: To evaluate the neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), platelet-to-lymphocyte ratio (PLR), and systemic immune-inflammation index (SII) in patients with non-arteritic anterior ischemic optic neuropathy (NAION). METHODS: Fifty-six patients with NAION and 60 age-sex matched healthy controls were included in the study. Demographic characteristics and laboratory findings of the patients and the controls were obtained from the electronic medical records. NLR, PLR, MLR, and SII were calculated and compared between the groups. Cutoff values were also determined. RESULTS: Neutrophil, monocyte and platelet counts were higher in the NAION group than in the control group, but the difference was not statistically significant (p > 0.05). The mean NLR and SII were higher in the NAION group than in the control group (p = 0.004 and p = 0.011, respectively). In the receiver operating characteristic curve analysis, the areas under the curve for NLR were 0.67, and NLR >1.79 predicted NAION with a sensitivity of 71% and specificity of 59%. The areas under the curve for SII was 0.66, and SII of >417 predicted NAION with a sensitivity of 71% and specificity of 49%. There was no significant difference in PLR and MLR between the groups (p = 0.105 and p = 0.347, respectively). CONCLUSIONS: The current study demonstrated that NAION patients had increased NLR and SII levels compared with control subjects. Elevated NLR and SII might serve as readily available inflammatory predictors in NAION patients.
format Online
Article
Text
id pubmed-7738228
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Korean Ophthalmological Society
record_format MEDLINE/PubMed
spelling pubmed-77382282020-12-23 Serum Inflammatory Biomarkers in Patients with Nonarteritic Anterior Ischemic Optic Neuropathy Koçak, Nurullah Eraydın, Bilge Turunç, Mustafa Yeter, Volkan Günögr, İnci Korean J Ophthalmol Original Article PURPOSE: To evaluate the neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), platelet-to-lymphocyte ratio (PLR), and systemic immune-inflammation index (SII) in patients with non-arteritic anterior ischemic optic neuropathy (NAION). METHODS: Fifty-six patients with NAION and 60 age-sex matched healthy controls were included in the study. Demographic characteristics and laboratory findings of the patients and the controls were obtained from the electronic medical records. NLR, PLR, MLR, and SII were calculated and compared between the groups. Cutoff values were also determined. RESULTS: Neutrophil, monocyte and platelet counts were higher in the NAION group than in the control group, but the difference was not statistically significant (p > 0.05). The mean NLR and SII were higher in the NAION group than in the control group (p = 0.004 and p = 0.011, respectively). In the receiver operating characteristic curve analysis, the areas under the curve for NLR were 0.67, and NLR >1.79 predicted NAION with a sensitivity of 71% and specificity of 59%. The areas under the curve for SII was 0.66, and SII of >417 predicted NAION with a sensitivity of 71% and specificity of 49%. There was no significant difference in PLR and MLR between the groups (p = 0.105 and p = 0.347, respectively). CONCLUSIONS: The current study demonstrated that NAION patients had increased NLR and SII levels compared with control subjects. Elevated NLR and SII might serve as readily available inflammatory predictors in NAION patients. Korean Ophthalmological Society 2020-12 2020-12-03 /pmc/articles/PMC7738228/ /pubmed/33307608 http://dx.doi.org/10.3341/kjo.2020.0075 Text en © 2020 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Koçak, Nurullah
Eraydın, Bilge
Turunç, Mustafa
Yeter, Volkan
Günögr, İnci
Serum Inflammatory Biomarkers in Patients with Nonarteritic Anterior Ischemic Optic Neuropathy
title Serum Inflammatory Biomarkers in Patients with Nonarteritic Anterior Ischemic Optic Neuropathy
title_full Serum Inflammatory Biomarkers in Patients with Nonarteritic Anterior Ischemic Optic Neuropathy
title_fullStr Serum Inflammatory Biomarkers in Patients with Nonarteritic Anterior Ischemic Optic Neuropathy
title_full_unstemmed Serum Inflammatory Biomarkers in Patients with Nonarteritic Anterior Ischemic Optic Neuropathy
title_short Serum Inflammatory Biomarkers in Patients with Nonarteritic Anterior Ischemic Optic Neuropathy
title_sort serum inflammatory biomarkers in patients with nonarteritic anterior ischemic optic neuropathy
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738228/
https://www.ncbi.nlm.nih.gov/pubmed/33307608
http://dx.doi.org/10.3341/kjo.2020.0075
work_keys_str_mv AT kocaknurullah seruminflammatorybiomarkersinpatientswithnonarteriticanteriorischemicopticneuropathy
AT eraydınbilge seruminflammatorybiomarkersinpatientswithnonarteriticanteriorischemicopticneuropathy
AT turuncmustafa seruminflammatorybiomarkersinpatientswithnonarteriticanteriorischemicopticneuropathy
AT yetervolkan seruminflammatorybiomarkersinpatientswithnonarteriticanteriorischemicopticneuropathy
AT gunogrinci seruminflammatorybiomarkersinpatientswithnonarteriticanteriorischemicopticneuropathy